Please assess the completion status of the following clinical trial:

Trial Title: Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Capable and willing to provide consent~2. history of clinically-diagnosed retinal microvascular diseases, including but not limited to diabetic retinopathy, retinal vein occlusion, idiopathic macular telangiectasias, hypertensive retinopathy, and age-related macular degeneration~3. At least 18 years of age~Exclusion Criteria:~1. Unable or unwilling to give consent~2. Under 18 years of age

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- retinal vascular occlusion arm (Type: OTHER): Patients with existing retinal microvascular disease will undergo imaging.

Based on this trial design, predict the completion outcome and termination type (if applicable).